WINNING STRATEGIES WASHINGTON

Lobbying for DBV TECHNOLOGIES · Pharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $40,000.00 income · posted Jul 20, 2025

Lobbying activity 1

Health Issues

Innovation in medical therapies to treat childhood food allergies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem